STREAM is the first large-scale, multi-country clinical trial to investigate shortened regimens for multidrugresistant tuberculosis (MDR-TB), and the first phase III trial to test the efficacy and safety of Bedaquiline, a new drug with a novel mechanism of action, within a shortened treatment regimen.
The trial established a Community Engagement (CE) Plan. The CE program was implemented at thirteen research sites within the STREAM trial, in seven countries. This paper sets out a summary of the experiences of CABs in connection with the STREAM clinical trial. It underlines relevant aspects that may be useful when planning and/or engaging communities in research. In conclusion, the experiences gained during STREAM, lead to both growing confidence in CE as a valuable process and community participation in advocacy.
Recent Abstracts
Effects of Heat on Early Childhood Development
Sportswashing through Media: Coca-Cola’s Olympic Play – A Research Report
Mais Dados Mais Saúde: Experiência De Discriminação Cotidiana Pela População Brasileira
What’s in Our Food?
Mais Dados Mais Saúde
Monitoramento de Estratégias pelo Fim da Violência contra Crianças e Adolescentes
The Power of Storytelling: Guidance for the Creation of Testimonials
Lead Poisoning and Early Childhood Development
Prioritizing Evidence Gaps: Air Pollution and Health Impacts of Climate Action
Raising Alcohol Taxes to Reduce Harm: Fact Sheets for Brazil